EP3860590
ETRASIMOD FOR USE IN METHODS FOR THE TREATMENT OF SCLERODERMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.10.2019EP published:
7.6.2023EP application number:
19790404.8
EPO information:
European Patent Register
Max expiry date:
2.10.2039
Title in English:
ETRASIMOD FOR USE IN METHODS FOR THE TREATMENT OF SCLERODERMALanguage of the patent:
English
Timeline
Today
3.10.2019EP application
7.6.2023EP Publication
Owner
Name:
Arena Pharmaceuticals, Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
ADAMS, John W.Address:
San Diego, California 92109, US
Priority
Number:
201862740855 PDate:
3.10.2018Country:
US
Classification
Categories:
A61K 31/404, A61P 37/00